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Abstract
Black men who have sex with men (MSM) in the United States are disproportionately impacted by 
HIV. To better understand this public health problem, we reviewed the literature to calculate an 
estimate of HIV incidence among Black MSM. We used this rate to model HIV prevalence over 
time within a simulated cohort, which we subsequently compared to prevalence from community-
based samples. We searched all databases accessible through PubMed, and Conference on 
Retroviruses and Opportunistic Infections abstracts for HIV incidence estimates among Black 
MSM. Summary HIV incidence rates and 95 % confidence intervals (CIs) were calculated using 
random effects models. Using the average incidence rate, we modeled HIV prevalence within a 
simulated cohort of Black MSM (who were all HIV-negative at the start) from ages 18 through 40. 
Based on five incidence rates totaling 2898 Black MSM, the weighted mean incidence was 4.16 % 
per year (95 % CI 2.76–5.56). Using this annual incidence rate, our model predicted that 39.94 % 
of Black MSM within the simulated cohort would be HIV-positive by age 30, and 60.73 % by 40. 
Projections were similar to HIV prevalence found in community-based samples of Black MSM. 
High HIV prevalence will persist across the life-course among Black MSM, unless effective 
prevention and treatment efforts are increased to substantially reduce HIV transmission among 
this underserved and marginalized population.
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Introduction
Black men who have sex with men (MSM) are estimated to comprise less than 1 % of the 
United States (US) population, but represent between 20 and 25 % of all new HIV infections 
nationally [1] Compared to other HIV-positive MSM, HIV-positive Black MSM are more 
likely to be unaware of their infection, experience lower rates of HIV care linkage and 
retention after diagnosis, are less likely to adhere to antiretroviral (ART) therapy, and less 
likely to attain viral suppression [2] In addition to individual clinical benefits, successful 
movement through the HIV care continuum limits new infections, as ART efficaciously 
inhibits HIV transmission (i.e., treatment as prevention) [3, 4]. HIV incidence among Black 
MSM, therefore, is a metric not only for how effective prevention efforts are operating for 
HIV-negative Black MSM, but also how successful public health and health care systems 
are serving HIV-positive Black MSM as they navigate the HIV care continuum.
A prior review of HIV incidence rates among MSM of all races and ethnicities living in the 
US yielded an annualized mean incidence of 2.39 % [5]. The authors calculated that this 
incidence rate would yield HIV prevalence of approximately 40 % in a cohort of MSM by 
the age of 40. However, this projection underestimates the burden of HIV infection among 
Black MSM. The plurality of HIV diagnoses among MSM in 2011 were among Black men 
(39 %) [1], and new infections continue to rise among young (i.e., aged 13–24 years) Black 
MSM [6] Forecasting future prevalence from available HIV incidence rates among Black 
MSM may prove useful in illustrating the HIV epidemic among Black MSM.
Producing samples from which to draw HIV incidence rates representative of Black MSM 
populations remains challenging. Though several community-based samples exist, their 
generalizability is limited by study-specific characteristics such as sampling method, 
location, and time. To mitigate limitations of any one incidence rate, we aim to 
systematically search the literature for studies that report unique incidence estimates of HIV 
infection among Black MSM. From this literature we employ meta-analytic methods to 
calculate an overall estimate of HIV incidence, which we then use to model HIV prevalence 
over time within a simulated cohort of Black MSM from age 18–40. We compare this 
projection to current HIV prevalence to examine how well the model describes current 
epidemio-logic dynamics among Black MSM. Our cohort starts at 18 as it is the youngest 
age at which we facilitate comparison of HIV prevalence among large samples of Black 
MSM, and concludes at 40 because the extant HIV incidence literature largely focuses on 
men until this age. Lastly, recommendations for intervention, research, and policy strategies 
are provided and placed in the context of the current and possible future of the HIV 
epidemic among Black MSM in the US.
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To meet the objectives of the current paper, we engaged in the following steps: (1) 
conducted a systematic review of the available data on HIV incidence among Black MSM; 
(2) generated the weighted mean HIV incidence; (3) modeled HIV prevalence over time 
using the weighted mean; and (4) compared modeled HIV prevalence with observed HIV 
prevalence data among Black MSM.
Systematic Review of HIV Incidence
Three co-authors conducted independent searches and extractions of the peer-reviewed 
literature that reported HIV incidence among Black MSM in the US. Searches were 
conducted among all databases accessible through PubMed. We used combinations of the 
following terms: “Black” OR “African American;” “MSM” OR “men who have sex with 
men” OR “gay” OR “bisexual;” HIV; “incidence” OR “seroincidence;” “annual” OR 
“yearly” OR “rate” OR “person year” or “person-year.” We also checked reference lists of 
manuscripts that provided HIV incidence estimates among Black MSM for additional 
publications. We contacted authors of manuscripts that reported incidence estimates among 
Black MSM for any necessary additional information (e.g., number of incident cases) if they 
were not included in the original publication. We employed the same search strategy for 
peer-reviewed abstracts from the most recent (2014) Conference on Retroviruses and 
Opportunistic Infections, recognizing the high likelihood of this research to appear in future 
peer-reviewed literature. We concluded our search on January 22, 2015.
We considered studies eligible for inclusion if they reported an estimate of HIV incidence 
among Black MSM between the ages of 18 and 40 in US. Several studies featured separate 
analyses from the same data source (e.g., HPTN 061), in which case only the parent 
manuscript presenting incidence for the entire sample was prioritized to the exclusion of 
others. We utilized manuscript author definition of Black MSM. A majority of studies 
defined Black as non-Hispanic Black or non-Hispanic African American, though others 
were inclusive of Caribbean Black or multiethnic Black as well. We allowed the term 
“MSM” to be inclusive of any same-sex sexual behavior between men regardless of sexual 
identity. All study publication dates were eligible for inclusion.
We excluded studies that presented incidence rates based on approximations rather than 
observed data, including surveillance systems. Because the total number of Black MSM at 
risk for HIV infection is estimated rather than measured in these studies, they could not be 
appropriately weighted in a summary estimate. This is why organizations such as the 
Centers for Disease Control and Prevention routinely release HIV incidence rates for 
demographic groups that can be enumerated with Census data (e.g., sex, race, age) but not 
transmission category (e.g., MSM, injection drug use) [6]. We note the high HIV prevalence 
among transgender populations, however, we also exclude any transgender-specific 
incidence estimates from analysis to yield a consistent definition of Black MSM across 
studies. Studies that did not contain any data from 1996 onwards (the introduction of highly 
active antiretroviral therapy) were also excluded. We did not impose exclusion criteria on 
how new infections were assessed.
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Analysis of Weighted Mean HIV Incidence
Summary HIV incidence rates and 95 % confidence intervals (CI) were calculated with 
Comprehensive Meta-Analysis software (Biostat, Inc., Englewood, NJ). We assigned 
weights to each rate that represented the inverse of that sample's variance, plus an estimate 
of the variance between samples. To account for heterogeneity among samples, we 
calculated I-squared statistics and conducted a random effects computational model that 
does not assume equality of variance [7]. Because young (≤30 years of age) Black MSM 
have experienced a marked increase in new infections [6], we also calculated a separate 
summary incidence rate for this subgroup of Black MSM.
Analysis of Modeled HIV Prevalence
Using the average incidence rate, we projected HIV prevalence over time within a simulated 
cohort of Black MSM from age 18–40. We defined the cohort with 0 % HIV infection at age 
18, whose size does not change over time, but is capable of engaging in sexual behavior 
with the universe of sexually active persons in the US. We also assumed that incidence was 
constant until age 40, no disease remission, and that HIV-specific and general mortality was 
negligible. The formula used to model prevalence then reduces to Pn+1 = Pn + I(1 – Pn), 
where I is our constant incidence rate, Pn is prevalence at age n, and Pn+1 the prevalence at 
age n + 1. These assumptions err on the side of presenting a conservative projection over 
time. For additional information about this modeling strategy see Stall et al. [5].
HIV Prevalence Model Compared with Current HIV Prevalence Among Black MSM
To contextualize model projections, we present existing HIV prevalence data among Black 
MSM, stratified by age, from two separate large data sources. The first is the 2008 National 
HIV Behavioral Surveillance System (NHBS). The second is from the first year (2014) of 
Promoting Our Worth, Equality, and Resilience (POWER), an ongoing study of Black MSM 
attending Black Pride events.
NHBS Sample—At current, the largest reported age-stratified sample of HIV prevalence 
among Black MSM is from the second MSM-specific cycle of data collection of the NHBS 
collected in 2008 [8] MSM were recruited across 21 cities using time–space sampling 
methods from a randomly selected subset of venues enumerated with formative research. 
Upon agreeing to participate in the NHBS, MSM complete an anonymous behavioral 
questionnaire and HIV testing. More detailed methods of the NHBS are published elsewhere 
[9]. At time of manuscript preparation, the third MSM-specific NHBS cycle for 2011 had 
been completed, though age-stratified HIV prevalence among Black MSM had not yet been 
published.
POWER Sample—We also present age-stratified prevalence estimates from POWER, an 
ongoing multi-site community-based sample of Black MSM collected in 2014 at Black Pride 
events in Atlanta, GA; Detroit, MI, Houston, TX, Philadelphia, PA, and Washington, DC. 
Similar to NHBS, this study employed random time-location sampling to maximize 
representativeness of Black MSM attending Black Pride events, and data were weighted for 
sampling design [10]. Study participants were offered free and confidential HIV testing, the 
results of which were linked to an anonymous questionnaire via a unique study identifier. 
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Participants opting out of confidential HIV testing were offered the option to anonymously 
provide antibody samples assessing their HIV status via OraQuick ADVANCE rapid 
HIV-1/2 oral fluid antibody testing (OraSure Technologies, Inc., Bethlehem, PA). All HIV 
testing was incentivized with $10, as was the initial questionnaire. This analysis excludes 
Black MSM who did not opt for HIV testing, unless they self-identified in the anonymous 




Our search yielded 113 studies. The process of study identification is depicted in Fig. 1. 
Studies that provided incidence estimates for Black MSM and their relevant characteristics 
are provided in Table 1. Though they met initial inclusion criteria, we excluded two 
estimates from our summary incidence calculation. The first was excluded because the 
sample was drawn exclusively from men attending a sexually transmitted disease clinic and 
so presents an inflated likelihood of HIV infection due to selection bias [11]. The second 
was excluded because we were unable to extract information about the number of incident 
cases or total person-years necessary for weighting the reported 14.7 % annual incidence 
rate [12]. In the event an incidence rate was inclusive of Black MSM younger than 18 or 
older than 40 it was included, provided the mean age was still between 18 and 40. We 
present estimates used to calculate summary incidence by time of data collection (Fig. 2).
Based on five incidence rates totaling 2898 Black MSM, the weighted mean incidence was 
calculated to be 4.16 % per year (95 % CI 2.76–5.56). For Black MSM ≤30 years of age, 
four studies totaling 2045 Black MSM yielded a weighted mean incidence of 6.73 % per 
year (95 % CI 5.10–8.37).
Estimated Incidence Rates for Black MSM Over Time
Substituting the average incidence of 4.16 % per year into the model of HIV prevalence over 
time results in a prediction of 8.15 % (95 % CI 5.44–10.89). of Black MSM within our 
simulated cohort living with HIV by age 20, 25.72 % (95 % CI 17.79–33.20) by 25, 39.94 % 
(95 % CI 28.52–49.92) by 30, 51.43 % (95 % CI 37.86–62.46) by 35, and 60.73 % (95 % CI 
45.98–71.86) by 40 as shown in Fig. 3.
Comparison of Projected and Observed HIV Prevalence Among Black MSM
The 2008 NHBS data reported HIV prevalence of 8.81 % for 18- and 19-year old Black 
MSM, with prevalence increasing to 19.71 % among Black MSM 20–24, and 30.35 % 
among Black MSM 25–29 [8]. POWER contains HIV testing data on 83.7 % of Black MSM 
respondents; of the 1563 Black MSM respondents, 1303 consented to receive an HIV test 
and/or reported living with HIV in the questionnaire. This yielded a weighted HIV 
prevalence of 14.0 % among Black MSM 18–19 years old, with prevalence increasing to 
28.7 % for those 20–24 years old, 31.9 % among 25–29 year olds, 33.2 % among 30–34 
year olds, 41.3 % among 35–39 year olds, and 51.4 % for Black MSM ≥40. We contrast 
2008 NHBS and POWER study sample characteristics in Table 2. Figure 3 illustrates the 
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projected HIV prevalence among the simulated cohort by age, with age-stratified prevalence 
from the NHBS and POWER samples.
Discussion
By presenting an estimate of current HIV incidence rates among Black MSM in the US, and 
its associated implications, we hope to draw renewed attention to an epidemic among a 
population that has long borne a disproportionate burden of new HIV infections. Stall et al. 
noted that a 2.39 % incidence rate would lead to an HIV prevalence of 40 % by age 40 
among gay men in the US, a situation they characterized as “running in place” [5]. Black 
MSM have an incidence rate almost twice that, with an even faster pace of new infections 
occurring among young Black MSM [6]. If Black MSM in the US formed a country today, it 
would have the highest HIV prevalence on the globe [13, 14]. Characterizing the outcomes 
of HIV prevention among Black MSM forces us to conclude that if it is going anywhere, it 
is running backwards. Our model projections are already within the limits of current HIV 
prevalence estimates; this is not an epidemic that could happen, but rather is happening. This 
endeavor is meant neither to stigmatize nor dishearten, but rather to serve as a call to action: 
we will not end the HIV epidemic in this country without a powerful and effective response 
to the HIV epidemic among Black MSM.
Despite the notable strengths of our approach, our analysis has several limitations. The first 
being that any summary estimate is only as meaningful as the quality of individual studies 
that comprise it. The few published incidence rates for Black MSM are primarily from 
samples of MSM in large cities and metropolitan areas. The omission of areas where Black 
MSM have relatively lower prevalence but high incidence (e.g., the South) [15] would 
suggest that published incidence rates—and by extension model projections—may fail to 
capture important regional variations [16]. Though incidence rates are higher among young 
Black MSM we assumed a uniform incidence and 0 % prevalence at age 18 to facilitate a 
conservative model. The model we used to project prevalence was intentionally simplistic 
and did not take into account variables known to influence infection and transmission rates 
(e.g., behavioral change after diagnosis [17], treatment as prevention [4], serosorting [18], 
network characteristics [19]), though to some extent these dynamics are reflected in the 
incidence estimates themselves. Also, our average incidence estimate only includes those 
studies we were able to identify in the peer-reviewed literature and as such suffers from the 
same limitations inherent in all systematic reviews [20]. In acknowledgement of these 
limitations, we used a random effects model to generate the summary incidence rate. 
Though resulting in a wider confidence interval it appropriately reflects the uncertainty 
inherent in using observed incidence rates, which reflect a complex 30 year history of the 
epidemic, to predict prevalence in a qualitatively different future. We provided two separate 
sources of age-stratified HIV prevalence among Black MSM that support our model 
projection, though we acknowledge these prevalence data may underestimate existing 
infections, as they are from samples that underrepresent Black MSM with high HIV-related 
morbidity, and exclude those who experienced premature mortality.
The challenge before us lies in developing strategies that render our projections inaccurate. 
A cornerstone of the National HIV/AIDS Strategy is to proportionately allocate resources to 
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communities according to epidemiologic need [21]. Yet an analysis by The Fenway Institute 
found that HIV prevention, risk reduction, and research funding for MSM, and Black MSM 
in particular, is disproportionately low [22]. Addressing the current epidemic requires at the 
very least a commensurate increase in resources for research and interventions targeting 
Black MSM. The high rate of new infections among Black MSM requires greater 
monitoring and faster reporting systems, as data can too quickly become inaccurate to 
inform timely public health interventions. With respect to intervention and policy, one of the 
most efficient methods to prevent additional infection is to focus on transmission. There will 
always be a role for primary prevention—individual behavior remains a proximal 
determinant of infection, and a recent modeling study has shown how a combination of 
condom use and pre-exposure prophylaxis (PrEP) could dampen current HIV incidence rates 
among Black MSM [23]. However, the lack of difference in sexual risk behaviors between 
Black MSM and other MSM [2], suggest interventions that focus on individual sexual 
behavior will have a limited impact in reducing disparities. Strategies that focus on 
navigating HIV-positive Black MSM through the care continuum to achieve viral 
suppression represent an ideal use of scarce public health resources. In addition to the large 
potential public health benefit, HIV-positive individuals experience a substantial direct 
health benefit from early diagnosis and viral suppression [24].
Hall et al. estimate that 38,920 additional HIV-positive Black MSM need to be on treatment 
just to raise viral suppression to 56 %, the same level experienced by White MSM aware of 
their infection [25]. Yet even this number is a far cry of what will be required to end the 
epidemic. For if we were to equalize the HIV care continuum between Black and White 
MSM today, it would only reduce incidence by 27 %, as excess incident infections would 
remain simply due to current disparities in HIV prevalence [26]. Ending disparities in new 
HIV infections is an important step to ending the HIV epidemic, but they cannot be 
confused as synonymous goals.
An assortment of effective and diverse policy actions that are capable of influence on a 
wide-scale over the long-term is necessary to lower the number of new HIV infections. 
Prioritizing access to treatment for all HIV-positive individuals is one immediate first step, 
as HIV-positive Black MSM are only about half as likely to have health insurance as other 
HIV-positive MSM [2]. The provision of Emergency Relief Funds, which effectively 
eliminated AIDS Drug Assistance Program waiting lists across the country in 2013, remains 
an instructive example of how targeted resource allocation can have a profound impact [27]. 
Though the Affordable Care Act will reduce disparities in access [28], Black MSM still 
experience significant barriers to care linkage, retention, and ART adherence [2]. A recent 
review found low availability of culturally competent services, and limited availability of 
HIV testing and prevention services in the communities where Black MSM live [29]. Even 
when services are available, stigma remains a powerful deterrent to their use [30]. Policies 
can remove structural sources of stigma; the Department of Justice has recently called for 
states to modify ineffective laws that criminalize HIV non-disclosure, invoking the National 
HIV/AIDS Strategy and scientific knowledge as an impetus for this change [31]. Finally, 
improving the health of Black MSM will require not only addressing sociocultural factors 
that facilitate HIV infection (e.g., homophobia, stigma, racism) [30], but also recognizing 
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that HIV infection is but one of many health outcomes born of structural inequalities that 
adversely affect the lives of Black men.
Research, intervention, and policy must work in concert to identify and modify contextual 
factors that pattern HIV infection and lower care utilization. To that end, public health must 
be mindful to engage, not simply target, communities of Black MSM at every opportunity. 
Understanding strategies that HIV-negative and HIV-positive Black MSM employ to remain 
healthy and thrive are poised to inform initiatives that have the greatest chance at making a 
positive impact because they originate from these communities [32]. PrEP is a contemporary 
example about the need for this engagement. Despite the potentially large benefit from PrEP 
use [23], we know incredibly little about the awareness, access, and utilization of PrEP 
among Black MSM, though preliminary research suggests they are low [33, 34]. 
Establishing meaningful community relationships is crucial to ensure Black MSM have the 
ability to weigh their options, decide what is most appropriate, and execute a personalized 
prevention portfolio. Yet absent changes in public health infrastructure simply launching 
awareness campaigns will have little effect. Stigma and medical mistrust limit the 
engagement of Black MSM with health care (including HIV care for Black MSM with 
diagnosed HIV infection) and will continue to serve as a barrier to not just PrEP use, but 
more general preventive health care services necessary for Black MSM to remain healthy 
[35].
Highlighting the specific needs of young Black MSM warrants special attention. Though 
working with youth requires specific consideration to a variety of factors salient to these 
populations [36], it remains necessary to better understand and reach these young Black 
MSM, as many are already diagnosed with HIV before 18 years of age [6, 8]. Though the 
amount of formally evaluated engagement with young Black MSM remains limited, efforts 
such as the HRSA-funded Special Projects of National Significance Young MSM of Color 
Initiative prove not only feasibility of such efforts but their value [37, 38].
Despite the alarming projections found in this paper, we caution against falling prey to a 
defeatist paradigm. Short of an effective vaccine or cure, there will not be one silver bullet 
that halts new infections and ensures those living with HIV receive the care they need. But 
to start running forward in addressing the HIV epidemic among Black MSM, we as a 
country must summon both the energy and investment to make up for the missed 
opportunities of the past. We have a greater diversity of prevention and treatment options 
than at any point during the history of the HIV epidemic, but their potential will not be 
realized until interventions and policies sufficiently reduce the gap between efficacy in the 
laboratory and effectiveness in communities.
The US has made an impressive commitment to ending the HIV epidemic around the world, 
and in several regards has made laudable progress towards that goal [39]. Just as the US has 
devoted resources beyond our borders, it must similarly act to end an epidemic which 
exceeds in magnitude that of many countries in the developing world. Invoking that spirit, 
we challenge the US to rise to the occasion and meet the needs of Black MSM, currently in 
the throes of a growing epidemic. Creating an AIDS-free generation requires no less than the 
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commitment and urgency owed to current and future generations of Black MSM living in 
the US.
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Estimates of HIV incidence of Black MSM over time, weighted by sample size
Matthews et al. Page 13














Existing HIV prevalence estimates among Black MSM by age, and projection based on 
annualized HIV incidence rate of 4.16 %
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Table 2
Characteristics of Black MSM in the National HIV Behavioral Surveillance (NHBS) and Promoting Our 
Worth, Equality, and Resilience (POWER) samples
NHBS POWER
Study period June–December 2008 April–September 2014




a 539/1895 (28.44 %) 492/1286 (38.26 %)
Sampling method Random time–space sampling Random time–space sampling
Location Atlanta, GA; Baltimore, MD; Boston, MA; Chicago, IL; Dallas, 
TX; Denver, CO; Detroit, MI; Houston, TX; Los Angeles, CA; 
Miami, FL; Nassau, NY; New Orleans, LA; New York, NY; 
Newark, NJ; Philadelphia, PA; San Diego, CA; San Francisco, 
CA; San Juan, PR; Saint Louis, MO; Seattle, WA; Washington, 
DC
Atlanta, GA; Detroit, MI; Houston, 
TX; Philadelphia, PA; Washington, DC
a
Not weighted for sampling design
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